Free Trial
→ Here’s How to Claim Your Stake in Elon’s Private Company, xAI (From Brownstone Research) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 4 of 15

Slide 4
Back to 3
Continue to 5
 
Back to 3
Continue to 5
 

Roivant Sciences (NASDAQ:ROIV)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
3 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$17.50 (92.7% Upside)

About Roivant Sciences

Roivant Sciences logoRoivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. More about Roivant Sciences
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/4/2025Cantor FitzgeraldUpgradeStrong-Buy
2/11/2025HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
1/30/2025Cantor FitzgeraldUpgradeStrong-Buy
11/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
9/19/2024Cantor FitzgeraldReiterated RatingOverweight
9/19/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
9/11/2024Bank of AmericaBoost Price TargetNeutral ➝ Neutral$12.00 ➝ $12.50
9/11/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
9/9/2024Cantor FitzgeraldReiterated RatingOverweight
8/19/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
Slide 4
Back to 3
Continue to 5
 

More From MarketBeat
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
7 Massive Growth Stocks to Own for the Next 10 Years
Many investors look to get in on the ground floor of a massive growth stock. For example, in 2024, a stock l...
MarketBeat
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
7 Stocks That Hold Appeal for Aggressive Investors
In times of market volatility, many investors sell stocks as part of a flight to safety. There's logic to this...
MarketBeat
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
7 Natural Gas Stocks to Own Before Winter
Before you can invest in natural gas stocks, it's important to understand how this industry is similar and dif...
MarketBeat